The Role of Computed Tomography in carcinoma of the breast: Review Article


  • Shweta Mandavkar
  • Suhas Tivaskar
  • Juhi Barai
  • Anurag Luharia



Computed Tomography, Breast Carcinoma, M.R.I., Mammography, Malignancy.


Breast malignancy is the most prevalent condition which occurs in young females. Breast malignancy frequently recurs in the axilla. The axilla is a common site for breast cancer recurrence. A nodal tumor can be felt, and computed tomography (C.T.) is usually used to differentiate reoccurring malignancy from the long-term surgery's consequences and radiation. The patient had a bulge that couldn't be felt, and C.T. was utilized to determine if a recurrent tumor was present. Because this patient's axilla had previously been irradiated, clinical examination was challenging. Only one patient had a lump that could not be palpated; thus, C.T. was utilized to rule out the possibility of a recurrent tumor. Clinical examination was impossible due to a previously irradiated 'wooden' axilla. C.T. scans failed to reveal the recurrence of cancer in the axilla. We conclude it is only beneficial when palpation of the axilla is difficult due to previous treatment. Careful palpation and aspiration cytology of any lump is key to diagnosing axillary tumor recurrence. A CT scan is unlikely to detect illness when there is no bulk on clinical examination. For decades, the chance of a breast cancer recurrence in the local-regional area following mastectomy has remained around the lo-30% range. External beam radiation therapy, the standard treatment, is effective in most cases in eradicating local illness, although recurrences occur in around half of the patients. Since 1982, 33 persons who have had such recurrences have obtained a computed tomography (C.T.) scan at our facility as it's all part of their diagnostic process. Accurate characterization and categorization of breast lump detected with C.T. enhance the value of the radiologist's report and contribute to relevant case management.







How to Cite

The Role of Computed Tomography in carcinoma of the breast: Review Article. (2022). Journal of Pharmaceutical Negative Results, 13(3), 1095-1100.